Hôpital Jean Jaurès

Psychotherapy enhanced by psychedelics has recently been found to be helpful for the treatment of several psychiatric disorders, notably depressive disorders. However, it has only been considered scarcely in patients suffering from personality disorders. Here, we report the case of a 37 years-old woman suffering from severe mixed personality disorder and ADHD. Alongside the beginning of her GPM-based psychotherapeutic treatment, and despite our concerns, she started closely monitored psychedelic micro-dosing, using products bought online, punctuated by occasional macro-dosing After one-year of this psychotherapy associated with concomitant independent use of psychedelics, paranoid, narcissistic and borderline personality dimensions were largely improved, as well as emotion regulation, impulsivity, mentalization abilities, and social functioning. Given the actual evidence regarding the efficacy of psychedelics to improve the latter four dimensions, given the patient's reported experience, and despite important limits, we make the hypothesis that the concomitant use of psychedelics has enhanced psychotherapy efficacy. Overall, this case asks the question of the potential usefulness of psychedelics associated with psychotherapy in patients with PD. Further pilot studies should be conducted on this issue.

Lors des débats qui président à la loi de 1910 sur les retraites ouvrières et paysannes, Jean Jaurès n’hésite pas dénoncer l’ignorance économique et la méfiance du mouvement ouvrier face à la capitalisation. Dans une filiation conceptuelle qui remonte aux Lumières, il vante les droits garantis par les mécanismes assurantiels, la fiabilité de la comptabilité administrative, la force politique de la démocratie des épargnants et la perspective d’assurer une ère de sécurité sociale qui s’étendra à l’indemnisation de la maladie et du chômage et à la réforme de la fiscalité. L’article suggère ainsi la nécessité d’une histoire longue de l’État-Providence, dont les acquis constituent le capital oublié du XXIe siècle, et interrogent la nature même de nos sociétés.

Herein, we present the case of a 55-year-old patient who developed a severe zoster reaction after receiving the AstraZeneca COVID-19 vaccine. Although zoster reactivation has already been observed with various vaccines, the extent and length of this reaction raise serious concerns. Hopefully, the outcome of this patient was favorable. The case of this patient, who could have only received a single dose of the vaccine, suggests that immunity after this type of vaccine vanishes rapidly and booster shots will be of crucial importance in the future.